Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Med BioGene Inc

Healthcare CA MBI.H

0.03CAD
0.00(0%)

Last update at 2026-06-02T13:30:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.010.06
LowHigh

Fundamentals

  • Previous Close 0.03
  • Market Cap0.35M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.06306M -0.05996M -0.05454M -0.06348M -0.05462M
Minority interest - - - - -
Net income -0.06306M -0.05996M -0.05454M -0.06348M -0.05462M
Selling general administrative 0.06M 0.06M 0.05M 0.06M 0.05M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation - - - - -
Ebit - -0.05996M -0.05454M -0.06348M -0.04638M
Ebitda -0.06306M -0.05996M -0.05454M -0.06348M -0.05462M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.06306M -0.05996M -0.05454M -0.06348M -0.05462M
Other operating expenses - - - - -
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 0.06M 0.06M 0.05M 0.06M 0.05M
Cost of revenue - - - - -
Total other income expense net - - - - -
Discontinued operations - - - - -
Net income from continuing ops -0.06306M -0.05996M -0.05454M -0.06348M -0.05462M
Net income applicable to common shares -0.06306M -0.05996M -0.05454M -0.06348M -0.05462M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.00300M 0.01M 0.08M 0.01M 0.00347M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 0.07M 0.09M 0.18M 0.05M 0.14M
Total stockholder equity -0.06624M -0.08122M -0.09634M -0.03727M -0.13382M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock 9.28M 9.21M 9.13M 9.13M 8.97M
Capital stock 9.28M 9.21M 9.13M 9.13M 8.97M
Retained earnings -14.72012M -14.65706M -14.59710M -14.54256M -14.47908M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.00041M 0.00919M 0.08M 0.01M 0.00240M
Cash and equivalents - - - - -
Total current liabilities 0.07M 0.09M 0.18M 0.05M 0.14M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 5.37M 5.37M 5.37M 5.37M 5.38M
Property plant equipment - - - - -
Total current assets 0.00300M 0.01M 0.08M 0.01M 0.00347M
Long term investments - - - - -
Net tangible assets - -0.08122M -0.09634M -0.03727M -0.13382M
Short term investments - - - - -
Net receivables - 0.00032M 0.00053M 0.00037M 0.00035M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.03M 0.03M 0.04M 0.04M 0.13M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments - - - - -
Change to liabilities 0.00000M -0.01028M 0.00189M -0.08945M 0.05M
Total cashflows from investing activities - - - - -
Net borrowings - - - - -
Total cash from financing activities -0.00394M 0.07M 0.07M 0.16M 0.16M
Change to operating activities 0.06M -0.07509M 0.13M 0.00148M -0.00020M
Net income -0.06306M -0.05996M -0.05454M -0.06348M -0.05462M
Change in cash -0.00879M -0.07004M 0.07M 0.00857M 0.00177M
Begin period cash flow 0.00919M 0.08M 0.01M 0.00240M 0.00063M
End period cash flow 0.00041M 0.00919M 0.08M 0.01M 0.00240M
Total cash from operating activities -0.00833M -0.14512M 0.07M -0.15146M -0.00830M
Issuance of capital stock 0.00000M 0.07M 0.00000M 0.16M -
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.00015M 0.00021M -0.00016M -0.00002M -0.00071M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.00394M -0.00394M -0.00394M -0.00490M -0.00490M
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.05M -0.08516M 0.13M -0.08798M 0.05M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -0.00833M -0.14512M 0.07M -0.15146M -0.00830M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
MBI-H
Med BioGene Inc		 - -% 0.03 - - - - -3.032
JUMP
Leveljump Healthcare Corp		 - -% 0.06 3.50 - 0.36 1.00 0.82 8.59
AVCR
Avricore Health Inc		 0.005 9.09% 0.06 - - 3.16 5.09 3.30 41.13
TELO
Telo Genomics Corp		 - -% 0.07 - - - 8.78 -6.3236
ARC
Arian Resources Corp.		 - -% 0.01 - - 2.12 - 15.59 2.25

Reports Covered

Stock Research & News

View All

Profile

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company was formerly known as Med BioGene Inc. and changed its name to Many Bright Ideas Technologies Inc. in June 2022. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Med BioGene Inc

598 East Kent Avenue South, Vancouver, BC, Canada, V5X 4V6

Key Executives

Name Title Year Born
Dr. Iain Weir-Jones FGS, P.Eng., Ph.D. Chairman & CEO NA
Mr. Ibrahim Ghobrial Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.